Art Polk

Inspirer
DISC Type : id

Head, Corporate Development (Pharmaceutical/Biotech and AI) at PacBio

New York City Metropolitan Area, United States

Overview

Art Polk is a fractional CFO/CBO and corporate development leader specializing in the intersection of finance, strategy, and science within the AI-era life sciences sector. An MBA from The Wharton School, he has co-founded multiple biotech startups, including Tinker Therapeutics and PetDx, focusing on therapeutics and advanced diagnostics.

He has a significant background in developing platforms for both human and animal health. His work has spanned novel therapeutics, multi-cancer early detection through liquid biopsy, and large-scale clinical genomics aimed at improving health equity for underrepresented populations.

Unique fact: Art co-authored a clinical study on a next-generation sequencing blood test for early cancer detection in over 1, 000 dogs and holds a related patent.

Personality Overview

Fast Adopter

Charming & Persuasive

Decisive

They measure a product on its merit but can be influenced by strong testimonials.  They respond well to objective pitches but also attach some value to relationships. They don’t mind taking a stand if they believe in something.

Topics They Care About

AI in Life Sciences
His focus is on bridging business models with AI-native workflows, generative biology, and multimodal data applications in biotech.
Biotech Startups
He has co-founded multiple companies (PetDx, Tinker Therapeutics) and serves as a fractional executive and advisor to several others, guiding them through various funding stages.
Veterinary Diagnostics
Co-founded PetDx, which developed a liquid biopsy platform for cancer detection in animals, and co-authored a major clinical validation study in dogs.

Media Appearances

Art has no verified media appearances

Work History

7-2025
Head, Corporate Development (Pharmaceutical/Biotech and AI) at PacBio
10-2024
Co-Founder, CFO/CBO at Tinker Therapeutics
7-2022 - 6-2025
Chief Financial Officer at Galatea Bio Inc.
4-2019 - 7-2023
Co-Founder, Chief Financial Officer, Head of Corporate Development at PetDx
1-2022 - 1-2023
Independent Consultant & Advisor at Polk Expeditions

Education

2024 - 2026
Master of Business Administration - MBA from The Wharton School
Bachelor of Business Administration - BBA from University of Wisconsin-Madison

More Information

Social Presence :

Prographics :

Exp : 6 Location : New York City Metropolitan Area, United States Job Level : Leadership Designation : Head, Corporate Development (Pharmaceutical/Biotech and AI) at PacBio
URL has been copied!

Insights For Selling To Art

During A Call Or A Meeting

DO's

  • Keep your pitch focused on the impact but insert some anecdotes into it
  • Clearly address the competitive aspects
  • Focus on the big picture and the strategic value of your product

DONT's

  • Don't be unorganized, be prepared for the pitch
  • Don’t be very informal even if they are being so themselves
  • Don’t keep repeating the same information, it could make them impatient

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Art is

  • Confidence in the product’s value is critical, followed by relationship and a sense of achievement.
  • Will you ever get a clear answer from Art

  • They will not hesitate to say no if they do not develop conviction.

Insights For Deal Planning

    How fast (or slow) will Art move?

  • If they develop confidence in your product and you, then they can make fast decisions.
  • Can Art take some risk or not?

  • If necessary, they have the ability to take risky decisions.

You And Art

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.